GENERAL10 Sept 2026
Already up 137% in 1 year still JM Financial sees more upside in this stock | Check target price, shareholding pattern | Stock Market News
Acutaas Chemicals rose 6.74% to ₹3,451.25 on Thursday, and JM Financial has restarted coverage with a buy rating and a ₹3,800 target over the next 12 months. The stock is already up 137% in a year, so that target implies about 10% more upside. If you hold speciality chemical shares, treat this as a broker's view, not a personal recommendation.
Key Statutory Highlights
- Acutaas Chemicals share price ended 6.74% higher at ₹3,451.25 on the BSE on Thursday, 10 September.
- JM Financial resumed coverage on Acutaas with a buy rating and a 12-month target price of ₹3,800, based on 45 times September 2028 estimated earnings per share.
- The stock has gained 137% over one year, and foreign portfolio investors held a 21.61% stake in the company by the end of the June quarter of FY27.
Actionable Advice for Taxpayers / Founders:If you are considering Acutaas Chemicals, read the latest quarterly results and shareholding data, and speak to your own advisor before acting on any broker rating.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: